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Abstract
Ulcerative colitis (UC) is an example of inflammatory bowel disease that can be manifested by extraintestinal complica-
tions including cardiac disorders. The most commonly reported — pericarditis — occurs in 0.23% of all UC patients. The 
knowledge about the etiology of pericarditis is important to implement accurate therapy. However, the diagnosis is not 
always clear and can be connected with diagnostic and therapeutic challenges. In this case, we present a perimyocar-
ditis in the course of UC exacerbation.
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Introduction
In clinical practice pericarditis is the most common disor-
der of the pericardium. The aetiology of acute pericarditis 
include infectious and non-infectious causes. Pericarditis 
may be isolated disorder or may occur as a part of sys-
temic disease [1]. Ulcerative colitis (UC) is an example 
of  inflammatory bowel disease (IBD) that not only affects 
the gastrointestinal tract but also can be associated with 
extraintestinal complications. Cardiac disorders seem to 
be uncommon but potentially serious manifestations. They 
can range from mild inflammations to pericardial tampo-
nade, cardiogenic shock and myocardial infarction [2, 3]. 
The most commonly reported — pericarditis — occurs in 
0.23% of all UC patients [4]. Nevertheless, the diagnosis 
is not always clear and can be related with diagnostic and 
therapeutic challenges. Therefore, we present a case of 
perimyocarditis in the course of UC which caused some 
diagnostic problems.
Case report
A 21-year-old woman with newly diagnosed ulcerative colitis, 
treated with small dose of sulfasalazine, was admitted ur-
gently to the hospital complaining of fever, weakness, chest 
pain and bloody diarrhoea (< 4 bloody stools/day). Blood 
analysis revealed anaemia (hemoglobin [Hb] 7.8 g/dL), 
hypokalemia (3.2 mmol/L), slightly elevated troponin 
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resonance imaging (MRI) was performed to assess the 
degree of myocardial involvement. Due to negative blood 
cultures and probable autoimmune aetiology of pericarditis, 
successful treatment with prednisolone 50 mg per day 
was started. In a couple of days alleviation of fever and 
chest pain was observed. Markers of inflammation and 
NT-proBNP level were normalizing. Control echocardiogra-
phy showed reduction of pleural and pericardial effusion 
and improvement of left ventricular contractility of the 
heart (Figure 2C, D). The patient was discharged in a good 
condition, free of symptoms. Prednisolone was prescribed 
orally with the recommendation of dose reduction. On the 
basis of overall clinical picture, echo and MRI results, myo-
carditis and pericarditis was confirmed, most likely caused 
by the main disease.
Discussion
Cardiac manifestations of UC may occur before, simulta-
neously or after the diagnosis of underlying disease. It 
should be emphasized that extraintestinal manifestations 
of IBD not always parallel the activity of the underlying 
disease. Temporal relationship between onset of UC flares 
and the course of cardiovascular manifestation may be 
difficult to define and can cause a significant challenge to 
physicians managing these patients. A multidisciplinary 
team approach is often needed for effective management.
In the process of differential diagnosis UC related pe-
ricarditis the drug-induced aetiology has to be taken into 
(0.028 μg/L) and D-dimers (1.94 mg/L). Laboratory test re-
vealed increased inflammatory markers: white blood count 
(WBC) — 14 ths/μL, C-reactive protein (CRP) — 230 mg/L 
and procalcitonin — 22 ng/mL. A chest radiograph showed 
no pulmonary infiltrative changes. Angio-CT excluded pul-
monary embolism. Abdominal and pelvic CT revealed no 
significant deviations apart from inflammatory features of 
the colon as in the UC. Patient received red cell concentrate 
transfusion. Optimal treatment with mesalazine (4 g/day) 
was instituted. After that the chest pain decreased, the 
stool frequency decreased with no bleeding, but patient’s 
condition was not improving. Due to persistent fever up 
to 41°C, hypotension (84/40 mm Hg), tachycardia (up to 
120/min), neutrophilic leukocytosis, increased CRP and 
high level of procalcitonin, the suspicion of septic shock 
was raised and combined wide spectrum antibiotic therapy 
(vancomycin and imipenem) was administered. Never-
theless patient’s condition deteriorated, chest pain reoc-
curred. Physical examination revealed pericardial friction 
rub and ankle oedema. In the following tests the levels of 
D-dimers (2,62 mg/L) and troponin I (0,73 μg/l) increased. 
NT-proBNP was significantly elevated to 15082 pg/mL. 
Electrocardiogram showed ST segment elevation in I, II, aVL 
and V2–V4 and PR depressions (Figure 1). Transthoracic 
echocardiography revealed pericardial effusion with fibrin 
strands and fluid in the pleural cavity (Figure 2A, B). Sys-
tolic function of the left ventricle was decreased — left 
ventricular ejection fraction (LVEF) was reduced to 38%. The 
diagnosis of perimyocarditis was made. Cardiac magnetic 
Figure 1. Electrocardiogram showing ST elevations and PR depressions
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account (toxic effects of — mesalazine and azathioprine). 
In the literature, cases of mesalazine-induced pericarditis 
have been reported [3, 5, 6]. One study recommend that 
among patients treated with mesalazine who present 
symptoms of perimyocarditis, mesalazine should be im-
mediately discontinued [3]. In our case, perimyocarditis 
occurred early after diagnosis of the UC, however severity 
of intestinal symptoms was disproportional to the syste-
mic involvement. Implementation of steroid therapy was 
problematic owing to highly increased inflammatory mar-
kers and possibility of sepsis. It has been reported that 
the intensive-care unit admissions of UC patients in 22% 
resulted from septic complications [7]. Finally, patient was 
treated successfully with mesalazine and prednisolone. 
The knowledge about the aetiology of pericarditis is im-
portant to implement accurate therapy [8].
Conclusions
Myocarditis is rarely taken into account as one of the pos-
sible extraintestinal manifestations of UC. Any patient with 
UC who develops symptoms of pericarditis require prompt 
diagnosis and accurate therapy with glucocorticosteroids 
and consideration of mesalazine cessation.
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Figure 2A–D. Transthoracic echocardiography: A, B. Echocardiographic findings before implementation of steroid therapy: 1.1–1.5 cm 
of pericardial effusion with features of fibrin and right atrial collapse; C, D. Regression of pericardial effusion at discharge
Streszczenie
Wrzodziejące zapalenie jelita grubego (UC) jest przykładem nieswoistej choroby zapalnej jelit, która może się manife-
stować objawami pozajelitowymi, w tym objawami ze strony układu sercowo-naczyniowego. Najczęściej stwierdzane 
zapalenie osierdzia występuje u 0,23% pacjentów z UC. Wiedza na temat etiologii zapalenia osierdzia jest niezbędna 
do wdrożenia właściwej terapii. Mimo to diagnoza nie zawsze jest łatwa i może być związana z wyzwaniami zarówno 
w zakresie diagnostyki jak i leczenia. Przedstawiony opis przypadku ilustruje problem zapalenia osierdzia i mięśnia 
sercowego w przebiegu UC.
Słowa kluczowe: wrzodziejące zapalenie jelita grubego, zapalenie osierdzia i mięśnia sercowego
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